Niverpharm

Niverpharm is a French pharmaceutical company and a subsidiary of Wockhardt, specializing in the production and distribution of medicines for various therapeutic areas. The company is part of the Wockhardt France (Holdings) group, which includes other entities like Laboratoires Negma and Pharma 2000. Niverpharm's product portfolio includes treatments for osteoarthritis, such as Zondar (diacerein), and phlebotonics like troxerutin for venous insufficiency and hemorrhoids. Headquartered in Elancourt, France, the company operates as a key marketing and distribution arm for Wockhardt's pharmaceutical products in the French market. It was acquired by Wockhardt in 2007 as part of the Negma Group acquisition and continues to be an active entity within the global Wockhardt network.